Indole-3-Acetamido-Polyamines as Antimicrobial Agents and Antibiotic Adjuvants
暂无分享,去创建一个
M. Bourguet-Kondracki | J. Brunel | B. Copp | Kenneth Sue | F. Rouvier | Melissa M. Cadelis | Evangelene S. Gill | Evangelene S Gill | Florent Rouvier
[1] M. Bourguet-Kondracki,et al. Structure–Activity Relationship Studies of Indolglyoxyl-Polyamine Conjugates as Antimicrobials and Antibiotic Potentiators , 2023, Pharmaceuticals.
[2] J. Haldar,et al. Antibiotic Adjuvants: A Versatile Approach to Combat Antibiotic Resistance , 2023, ACS omega.
[3] M. Bourguet-Kondracki,et al. Spermine Derivatives of Indole‐3‐carboxylic Acid, Indole‐3‐acetic Acid and Indole‐3‐acrylic Acid as Gram‐Negative Antibiotic Adjuvants , 2020, ChemMedChem.
[4] J. Haldar,et al. Lysine-based Small Molecule Sensitizes Rifampicin and Tetracycline against Multidrug-resistant Acinetobacter baumannii and Pseudomonas aeruginosa. , 2019, ACS infectious diseases.
[5] M. Bourguet-Kondracki,et al. Exploration of the antibiotic potentiating activity of indolglyoxylpolyamines. , 2019, European journal of medicinal chemistry.
[6] M. Bourguet-Kondracki,et al. 6-Bromoindolglyoxylamido derivatives as antimicrobial agents and antibiotic enhancers. , 2019, Bioorganic & medicinal chemistry.
[7] J. Brunel,et al. Antibiotic Adjuvants: Make Antibiotics Great Again! , 2019, Journal of medicinal chemistry.
[8] B. Copp,et al. Synthesis and antimalarial evaluation of artesunate-polyamine and trioxolane-polyamine conjugates. , 2017, European journal of medicinal chemistry.
[9] S. Tyner,et al. SPR741, an Antibiotic Adjuvant, Potentiates the In Vitro and In Vivo Activity of Rifampin against Clinically Relevant Extensively Drug-Resistant Acinetobacter baumannii , 2017, Antimicrobial Agents and Chemotherapy.
[10] R. Melander,et al. The Challenge of Overcoming Antibiotic Resistance: An Adjuvant Approach? , 2017, ACS infectious diseases.
[11] K. Bush,et al. β-Lactams and β-Lactamase Inhibitors: An Overview. , 2016, Cold Spring Harbor perspectives in medicine.
[12] Lucinda V. Jackson,et al. An Orally Bioavailable, Indole-3-glyoxylamide Based Series of Tubulin Polymerization Inhibitors Showing Tumor Growth Inhibition in a Mouse Xenograft Model of Head and Neck Cancer. , 2015, Journal of Medicinal Chemistry.
[13] M. Cooper,et al. Helping Chemists Discover New Antibiotics. , 2015, ACS infectious diseases.
[14] J. Bolla,et al. New Ianthelliformisamine derivatives as antibiotic enhancers against resistant Gram-negative bacteria. , 2014, Journal of medicinal chemistry.
[15] Patricia Bernal,et al. Antibiotic adjuvants: identification and clinical use , 2013, Microbial biotechnology.
[16] Eric D. Brown,et al. Discovery of antibiotic adjuvants , 2013, Nature Biotechnology.
[17] J. Sarles,et al. Genomic analysis of an emerging multiresistant Staphylococcus aureus strain rapidly spreading in cystic fibrosis patients revealed the presence of an antibiotic inducible bacteriophage , 2009, Biology Direct.
[18] Lijun Sun,et al. Indole- and indolizine-glyoxylamides displaying cytotoxicity against multidrug resistant cancer cell lines. , 2008, Bioorganic & medicinal chemistry letters.
[19] I. Gilbert,et al. Synthesis and biological evaluation of s-triazine substituted polyamines as potential new anti-trypanosomal drugs. , 2001, Journal of medicinal chemistry.
[20] I. Gilbert,et al. Nitrile reduction in the presence of Boc-protected amino groups by catalytic hydrogenation over palladium-activated Raney-nickel. , 2001, The Journal of organic chemistry.
[21] E. Modest,et al. ANALOGS OF SPERMINE AND SPERMIDINE. I. SYNTHESIS OF POLYMETHYLENEPOLYAMINES BY REDUCTION OF CYANOETHYLATED ALPHA,OMEGA-ALKYLENEDIAMINES. , 1964, Journal of medicinal chemistry.
[22] D. Pompliano,et al. Drugs for bad bugs: confronting the challenges of antibacterial discovery , 2007, Nature Reviews Drug Discovery.